Clinical trials
Phase 2 Bone Marrow Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Center for International Blood and Marrow Transplant Research | 2 |
| Gilead Sciences | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Novartis Pharmaceuticals | 1 |
| Orca Biosystems, Inc. | 1 |
| Sierra Oncology LLC - a GSK company | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Marrow Diseases | 8 |
| Hematologic Diseases | 8 |
| Leukemia | 7 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Myeloproliferative Disorders | 4 |
| Neoplasms | 4 |
| Neoplasms by Histologic Type | 4 |
| Immune System Diseases | 3 |
| Immunoproliferative Disorders | 3 |
| Leukemia, Biphenotypic, Acute | 3 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.